M Eckert

682 total citations
16 papers, 580 citations indexed

About

M Eckert is a scholar working on Psychiatry and Mental health, Pharmacology and Analytical Chemistry. According to data from OpenAlex, M Eckert has authored 16 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 4 papers in Pharmacology and 4 papers in Analytical Chemistry. Recurrent topics in M Eckert's work include Epilepsy research and treatment (7 papers), Analytical Methods in Pharmaceuticals (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). M Eckert is often cited by papers focused on Epilepsy research and treatment (7 papers), Analytical Methods in Pharmaceuticals (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). M Eckert collaborates with scholars based in Switzerland, Germany and Austria. M Eckert's co-authors include W H Ziegler, P. Heizmann, C Crevoisier, Peter H. Hinderling, R. Amrein, B. Oosterhuis, P.R. Farrow, Philippe Coassolo, R. Besser and S. Gasić and has published in prestigious journals such as British Journal of Clinical Pharmacology, European Journal of Clinical Pharmacology and The Journal of Clinical Pharmacology.

In The Last Decade

M Eckert

16 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Eckert Switzerland	9	212	151	129	96	89	16	580
W H Ziegler Switzerland	8	288 1.4×	177 1.2×	164 1.3×	136 1.4×	100 1.1×	11	694
C Crevoisier Switzerland	17	205 1.0×	143 0.9×	148 1.1×	99 1.0×	162 1.8×	40	888
G. Ziegler Germany	12	280 1.3×	119 0.8×	208 1.6×	117 1.2×	90 1.0×	19	751
K. W. Harper United Kingdom	8	313 1.5×	56 0.4×	122 0.9×	115 1.2×	82 0.9×	10	521
J. M. Scavone United States	11	99 0.5×	90 0.6×	53 0.4×	60 0.6×	107 1.2×	19	421
N. J. Halliday United States	9	275 1.3×	50 0.3×	107 0.8×	103 1.1×	77 0.9×	17	524
P.J. HOWARD United Kingdom	17	338 1.6×	50 0.3×	120 0.9×	87 0.9×	189 2.1×	37	724
Virginia D. Schmith United States	18	460 2.2×	71 0.5×	191 1.5×	134 1.4×	59 0.7×	49	1.2k
H. G. Giles Canada	15	63 0.3×	88 0.6×	139 1.1×	21 0.2×	106 1.2×	33	703
Pim J. Hennis Netherlands	17	521 2.5×	57 0.4×	71 0.6×	129 1.3×	46 0.5×	24	900

Countries citing papers authored by M Eckert

Since Specialization

Citations

This map shows the geographic impact of M Eckert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Eckert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Eckert more than expected).

Fields of papers citing papers by M Eckert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Eckert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Eckert. The network helps show where M Eckert may publish in the future.

Co-authorship network of co-authors of M Eckert

This figure shows the co-authorship network connecting the top 25 collaborators of M Eckert. A scholar is included among the top collaborators of M Eckert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Eckert. M Eckert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Eckert, M & R. Besser. (2008). Schnelle Levetiracetam-Infusion. Aktuelle Neurologie. 35(5). 211–213. 4 indexed citations

Wiegand, Michael H., et al.. (2001). [Effectiveness of zopiclone in disorders of initiating and maintaining sleep. Results of a drug monitoring study in 811 general practices].. PubMed. 119(1). 25–32. 1 indexed citations

Farrow, P.R., et al.. (1989). Effects of alpha‐interferon on theophylline pharmacokinetics and metabolism.. British Journal of Clinical Pharmacology. 27(6). 795–802. 45 indexed citations

Nilsen, Odd G., et al.. (1988). Single and multiple dose pharmacokinetics of tenoxicam in the elderly. European Journal of Clinical Pharmacology. 35(5). 563–566. 11 indexed citations

Hinderling, Peter H., et al.. (1986). Comparative pharmacokinetics and cardiovascular effects of tiapamil in healthy volunteers and patients with hepatic cirrhosis. European Journal of Clinical Pharmacology. 31(4). 397–404. 3 indexed citations

Eckert, M, et al.. (1984). Pharmacokinetics and Hemodynamic Effects of Tiapamil: Exercise Performance, Thallium Stress Scintigraphy, and Radionuclide Ventriculography. The Journal of Clinical Pharmacology. 24(4). 165–173. 2 indexed citations

Heizmann, P., M Eckert, & W H Ziegler. (1983). Pharmacokinetics and bioavailability of midazolam in man.. British Journal of Clinical Pharmacology. 16(S1). 43S–49S. 245 indexed citations

Amrein, R., et al.. (1983). Pharmacokinetic and clinical considerations in the choice of a hypnotic.. British Journal of Clinical Pharmacology. 16(S1). 5S–10S. 13 indexed citations

Ziegler, W H, et al.. (1983). Comparison of the effects of intravenously administered midazolam, triazolam and their hydroxy metabolites.. British Journal of Clinical Pharmacology. 16(S1). 63S–69S. 80 indexed citations

10.

Crevoisier, C, W H Ziegler, M Eckert, & P. Heizmann. (1983). Relationship between plasma concentration and effect of midazolam after oral and intravenous administration.. British Journal of Clinical Pharmacology. 16(S1). 51S–61S. 98 indexed citations

11.

Eckert, M, et al.. (1983). Relationship between pharmacokinetic and pharmacodynamic behaviour of bufuralol and its metabolite Ro 3-7410 in hypertensive patients. European Journal of Clinical Pharmacology. 24(4). 479–484. 5 indexed citations

12.

Eckert, M & Peter H. Hinderling. (1981). Atropine: A sensitive gas chromatography—mass spectrometry assay and prepharmacokinetic studies. Inflammation Research. 11(5). 520–531. 24 indexed citations

13.

Ziegler, W H, et al.. (1981). [Relationship between clinical effects and pharmacokinetics of midazolam on i.m. and i.v. application to volunteers/1st comm.: Clinical aspects (author's transl)].. PubMed. 31(12a). 2206–10. 8 indexed citations

14.

Amrein, R., et al.. (1981). [Pharmacokinetics of midazolam after i.v. administration (author's transl)].. PubMed. 31(12a). 2202–5. 17 indexed citations

15.

Crevoisier, C, et al.. (1981). [Relation between the clinical effect and the pharmacokinetics of midazolam following i.m. and i.v. administration/2nd comm.: Pharmacokinetical aspects (author's transl)].. PubMed. 31(12a). 2211–5. 23 indexed citations

16.

Amrein, R. & M Eckert. (1980). [Pharmacokinetics of soporific drugs].. PubMed. 56(16). 1163–71. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact